# A Study of Tirzepatide (LY3298176) in Healthy Lactating Females

> **NCT05978713** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 11 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Tirzepatide

## Key facts

- **NCT ID:** NCT05978713
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-31
- **Primary completion:** 2024-03-12
- **Final completion:** 2024-03-12
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05978713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05978713, "A Study of Tirzepatide (LY3298176) in Healthy Lactating Females". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05978713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*